Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $1.34M in the quarter ending September 30, 2024, a decrease of -71.25%. This brings the company's revenue in the last twelve months to $6.74M, down -69.69% year-over-year. In the year 2023, Arbutus Biopharma had annual revenue of $18.14M, down -53.51%.

• Revenue (ttm): $6.74M
• Revenue Growth: -69.69%
• P/S Ratio: 91.48
• Revenue / Employee: $92,356
• Employees: 73
• Market Cap: 648.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	18.14M	-20.88M	-53.51%
Dec 31, 2022	39.02M	28.03M	255.11%
Dec 31, 2021	10.99M	4.07M	58.92%
Dec 31, 2020	6.91M	903.00K	15.02%
Dec 31, 2019	6.01M	66.00K	1.11%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.